๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost effectiveness & benefits of photovoltaics in the Gambia

โœ Scribed by U. Able-Thomas; R. Hill; P. O'Keefe; N.M. Pearsall


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
202 KB
Volume
5
Category
Article
ISSN
0960-1481

No coin nor oath required. For personal study only.

โœฆ Synopsis


This paper will discuss the socio-economic benefits that the Gambia has derived from photovoltaics (PV) and its future potential. Technical performance, reliability and cost estimates are assessed for some PV applications.


๐Ÿ“œ SIMILAR VOLUMES


Dissemination of photovoltaics in The Ga
โœ U. Able-Thomas; R. Hill; P. O'Keefe; N.M. Pearsall ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 584 KB
Future benefits and cost-effectiveness o
โœ Peter J. Littrup ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 2 views

Estimates of cost-effectiveness for prostate carcinoma screening require a review of current data, modeling efforts, and perspectives on societal impact and costs. ## METHODS. Recent data from the cancer registry of the Michigan Department of Community Health was assessed for incidence trends in r

Statistical determination of cost-effect
โœ Eugene M. Laska; Morris Meisner; Carole Siegel; Joseph Wanderling ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB ๐Ÿ‘ 1 views

## Abstract Statistical methods are given for producing a costโ€effectiveness frontier for an arbitrary number of programs. In the deterministic case, the net health benefit (NHB) decision rule is optimal; the rule funds the program with the __largest positive__ NHB at each __ฮป__, the amount a decis

Discounting for health effects in costโ€“b
โœ Hugh Gravelle; Dave Smith ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 118 KB ๐Ÿ‘ 1 views

## Abstract When health effects can be valued in monetary terms, as in costโ€“benefit analysis, they should be discounted at the same rate as costs. If health effects are measured in quantities (e.g. quality adjusted life years) as in costโ€effectiveness analysis (CEA) and the value of health effects

Bayesian cost-effectiveness analysis wit
โœ Miguel A. Negrรญn; Francisco J. Vรกzquez-Polo ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 263 KB ๐Ÿ‘ 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d